YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG: 1558)
Hong Kong
· Delayed Price · Currency is HKD 9.56
-0.10 (-1.04%)
Dec 31, 2024, 12:08 PM HKT
YiChang HEC ChangJiang Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5,540 | 6,295 | 3,745 | 913.79 | 2,348 | 6,224 | Upgrade
|
| Revenue Growth (YoY) | -2.13% | 68.08% | 309.83% | -61.08% | -62.27% | 147.92% | Upgrade
|
| Cost of Revenue | 1,169 | 1,309 | 898.88 | 430.09 | 351.55 | 921.82 | Upgrade
|
| Gross Profit | 4,371 | 4,986 | 2,846 | 483.7 | 1,997 | 5,302 | Upgrade
|
| Selling, General & Admin | 1,860 | 1,933 | 1,555 | 880.07 | 1,472 | 2,864 | Upgrade
|
| Research & Development | 359.95 | 192.29 | 129.61 | 109.67 | 92.45 | - | Upgrade
|
| Other Operating Expenses | -17.13 | 63.83 | 842.69 | -51.11 | -397.14 | -96.51 | Upgrade
|
| Operating Expenses | 2,234 | 2,196 | 2,523 | 941.81 | 1,163 | 2,773 | Upgrade
|
| Operating Income | 2,137 | 2,790 | 322.72 | -458.11 | 833.69 | 2,530 | Upgrade
|
| Interest Expense | -144.98 | -227.4 | -281.65 | -243.81 | -244.21 | -204.5 | Upgrade
|
| Interest & Investment Income | 74.72 | 62.42 | 6.74 | 11.35 | 24.99 | 36.04 | Upgrade
|
| Earnings From Equity Investments | -0.03 | -0.03 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 33.71 | -16.86 | -241.43 | 49.2 | 150.14 | -87.17 | Upgrade
|
| EBT Excluding Unusual Items | 2,101 | 2,608 | -193.62 | -641.37 | 764.61 | 2,274 | Upgrade
|
| Impairment of Goodwill | - | - | -75.9 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.87 | 4.39 | 522.7 | 19.24 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.23 | -0.53 | -0.82 | -19.07 | -5.27 | -4.83 | Upgrade
|
| Asset Writedown | -422.9 | -485.39 | -212.94 | -25.98 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 251.09 | - | Upgrade
|
| Pretax Income | 1,678 | 2,127 | 39.42 | -667.18 | 1,010 | 2,269 | Upgrade
|
| Income Tax Expense | 161.82 | 270.95 | -9.82 | -79.46 | 173.02 | 361.87 | Upgrade
|
| Earnings From Continuing Operations | 1,517 | 1,856 | 49.24 | -587.72 | 837.41 | 1,907 | Upgrade
|
| Minority Interest in Earnings | 131.23 | 136.8 | 27.36 | 0.08 | 2.04 | 11.52 | Upgrade
|
| Net Income | 1,648 | 1,993 | 76.6 | -587.65 | 839.46 | 1,919 | Upgrade
|
| Net Income to Common | 1,648 | 1,993 | 76.6 | -587.65 | 839.46 | 1,919 | Upgrade
|
| Net Income Growth | 44.69% | 2501.23% | - | - | -56.25% | 103.57% | Upgrade
|
| Shares Outstanding (Basic) | 880 | 880 | 880 | 880 | 881 | 889 | Upgrade
|
| Shares Outstanding (Diluted) | 880 | 880 | 880 | 880 | 1,106 | 1,010 | Upgrade
|
| Shares Change (YoY) | - | - | - | -20.42% | 9.51% | 11.69% | Upgrade
|
| EPS (Basic) | 1.87 | 2.26 | 0.09 | -0.67 | 0.95 | 2.16 | Upgrade
|
| EPS (Diluted) | 1.87 | 2.26 | 0.09 | -0.67 | 0.53 | 2.07 | Upgrade
|
| EPS Growth | 44.49% | 2496.15% | - | - | -74.18% | 98.29% | Upgrade
|
| Free Cash Flow | -77.21 | 1,329 | 1,130 | -1,019 | 305.33 | 1,218 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | 1.51 | 1.28 | -1.16 | 0.28 | 1.21 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.100 | 0.650 | Upgrade
|
| Dividend Growth | - | - | - | - | -84.62% | 30.00% | Upgrade
|
| Gross Margin | 78.89% | 79.21% | 76.00% | 52.93% | 85.03% | 85.19% | Upgrade
|
| Operating Margin | 38.58% | 44.33% | 8.62% | -50.13% | 35.50% | 40.64% | Upgrade
|
| Profit Margin | 29.74% | 31.66% | 2.05% | -64.31% | 35.75% | 30.83% | Upgrade
|
| Free Cash Flow Margin | -1.39% | 21.12% | 30.17% | -111.49% | 13.00% | 19.57% | Upgrade
|
| EBITDA | 2,519 | 3,172 | 691.48 | -206.55 | 950.24 | 2,611 | Upgrade
|
| EBITDA Margin | 45.47% | 50.40% | 18.46% | -22.60% | 40.47% | 41.96% | Upgrade
|
| D&A For EBITDA | 382.06 | 382.3 | 368.76 | 251.55 | 116.54 | 81.83 | Upgrade
|
| EBIT | 2,137 | 2,790 | 322.72 | -458.11 | 833.69 | 2,530 | Upgrade
|
| EBIT Margin | 38.58% | 44.33% | 8.62% | -50.13% | 35.50% | 40.64% | Upgrade
|
| Effective Tax Rate | 9.64% | 12.74% | - | - | 17.12% | 15.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.